How many pills of serputinib/serpatinib should be taken every day and the dosage is appropriate?

Selpercatinib (Selpercatinib) is a targeted drug used to treat specific gene mutation-positive cancers. Patients must strictly follow the doctor's dosage instructions when using it. Normally, the recommended dose of Seputinib is to be taken once daily, and the number and strength of tablets taken each time will be determined based on the patient's specific condition, weight, and tolerance. The common dosage is 80mg or 120mg tablets taken daily. The specific dosage needs to be adjusted by the doctor according to individual differences.

In clinical use, doctors will adjust the dosage of seputinib according to the patient's treatment response and adverse reactions to ensure maximum efficacy and minimum side effects. Typically, patients begin treatment with recommended doses, which are then dynamically adjusted based on efficacy and tolerability. If a patient experiences serious adverse reactions, the doctor may recommend temporarily reducing or discontinuing the dose, and then resume the dose after symptoms subside.

It should be noted that seputinib should be taken under the guidance of a doctor, and do not increase or decrease the dose on your own or stop the drug at will. Following the prescribed dosage not only ensures the therapeutic effect of the drug but also reduces the risk of side effects. While taking the medicine, patients should regularly undergo relevant examinations, such as liver function and kidney function assessment, and promptly report their physical condition to the doctor.

In addition, the taking time of seputinib is also relatively flexible. It is generally recommended to take it at a fixed time every day to maintain stable blood concentration. If you miss a dose, you should take it as soon as possible, but if it is close to the next dose time, you should skip the missed dose to avoid overdose. In short, reasonable dosage arrangements and standardized medication habits are crucial to the efficacy of seprotinib.

Reference materials:https://en.wikipedia.org/wiki/Selpercatinib